Viatris (VTRS) Retained Earnings (2018 - 2026)
Viatris (VTRS) recorded quarterly Retained Earnings of -$2.8 billion in Q1 2026, down 3.43% quarter-over-quarter from -$2.7 billion in Q4 2025, and down 1328.52% on a YoY basis from $227.9 million in Q1 2025.
Viatris (VTRS) Retained Earnings (2018 - 2026) Analysis & Trends
Viatris' Retained Earnings history runs 9 years deep, the most recent figure standing at -$2.8 billion for Q1 2026.
- In Q1 2026, Retained Earnings fell 1328.52% year-over-year to -$2.8 billion; the TTM figure through Mar 2026 stood at -$2.8 billion (down 1328.52% YoY), while the FY2025 annual figure was -$2.7 billion, down 179.18% from the prior year.
- Retained Earnings was -$2.8 billion for Q1 2026 at Viatris, down from -$2.7 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $4.6 billion in Q4 2023 to a low of -$3.8 billion in Q3 2022.
- Historically, Retained Earnings has averaged -$1.1 billion across 5 years, with a median of -$2.8 billion in 2022.
- The sharpest annual moves came in 2023 and 2026: Retained Earnings soared 268.03% in 2023, then plunged 1328.52% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$2.8 billion in 2022, then jumped by 268.03% to $4.6 billion in 2023, then slipped by 26.31% to $3.4 billion in 2024, then plunged by 179.18% to -$2.7 billion in 2025, then fell by 3.43% to -$2.8 billion in 2026.
- The last three Retained Earnings figures came in at -$2.8 billion (Q1 2026), -$2.7 billion (Q4 2025), and -$48.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Viatris | - | - | 1.16 Bn | -2.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.80 Bn |
| Dec 31, 2025 | -2.71 Bn |
| Sep 30, 2025 | -48.20 Mn |
| Jun 30, 2025 | 80.00 Mn |
| Mar 31, 2025 | 227.90 Mn |
| Dec 31, 2024 | 3.42 Bn |
| Sep 30, 2024 | 4.08 Bn |
| Jun 30, 2024 | -2.98 Bn |
| Mar 31, 2024 | -2.94 Bn |
| Dec 31, 2023 | 4.64 Bn |
| Sep 30, 2023 | -3.21 Bn |
| Jun 30, 2023 | -3.01 Bn |
| Mar 31, 2023 | -2.76 Bn |
| Dec 31, 2022 | -2.76 Bn |
| Sep 30, 2022 | -3.76 Bn |
| Jun 30, 2022 | -2.90 Bn |
| Mar 31, 2022 | -2.06 Bn |
| Dec 31, 2021 | -1.74 Bn |
| Sep 30, 2021 | -1.47 Bn |
| Jun 30, 2021 | -1.21 Bn |